AMICUS THERAPEUTICS, INC. — Director's Dealing 2011

Jan 19, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2011-01-03

Reporting Person: Dilone Enrique (VP, Technical Operations)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$9.83	2019-08-31	Common Stock (12000)		Direct
Stock Options (right to buy)	$4.16	2019-11-16	Common Stock (20000)		Direct
Stock Options (right to buy)	$3.32	2020-03-16	Common Stock (5000)		Direct
Stock Options (right to buy)	$2.81	2020-06-15	Common Stock (8000)		Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on August 31, 2010. The remaining options vest and become exercisable in a series of thirty-six equal monthly installments, beginning on September 1, 2010.

F2: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vested on November 16, 2010. The remaining options vest and become exercisable in a series of thirty-six equal monthly installments, beginning on December 1, 2010.

F3: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, will vest on March 16, 2011. The remaining options will vest and become exercisable in a series of thirty-six equal montly installments, beginning on April 1, 2011.

F4: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, will vest on June 15, 2011. The remaining options will vest and become exercisable in a series of thirty-six equal montly installments, beginning on July 1, 2011.